Lv31
370 积分 2022-05-11 加入
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐BCMA CAR T‐cell‐based therapy
27分钟前
待确认
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
50分钟前
已关闭
In vivo chimeric antigen receptor (CAR)-T cell therapy
2小时前
已完结
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma
9天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
24天前
已完结
Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin
1个月前
已完结
DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in B-cell Acute Lymphoblastic Leukemia
1个月前
已完结
From bench to bloodstream: Lipid nanoparticles drive on-demand CAR-T cells
1个月前
已完结
Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor‐overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors
1个月前
已完结
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
1个月前
已完结